ClinicalTrials.Veeva

Menu

Irrigation of Bupivacaine at the Surgical Bed for Postoperative Pain Relief After Laparoscopic Cholecystectomy for Acute Cholecystitis

Z

Ziauddin University

Status and phase

Completed
Phase 4

Conditions

Postoperative Pain
Acute Cholecystitis

Treatments

Drug: Bupivacaine 0.5%
Drug: Normal Saline 0.9%

Study type

Interventional

Funder types

Other

Identifiers

NCT07851935
11150925UASUR

Details and patient eligibility

About

This study aims to compare the effectiveness of irrigation of 0.5% bupivacaine versus normal saline at the gallbladder surgical bed in reducing postoperative pain following laparoscopic cholecystectomy for acute cholecystitis. Postoperative pain remains a common concern despite the minimally invasive nature of laparoscopic surgery. The study evaluates pain intensity at 4, 8, and 12 hours after surgery using the Visual Analogue Scale (VAS).

Full description

Laparoscopic cholecystectomy is the standard treatment for acute cholecystitis. Although associated with reduced surgical trauma and shorter hospital stays, postoperative pain remains a significant challenge. Pain may arise from port-site trauma, visceral irritation, and diaphragmatic irritation.

Bupivacaine is a long-acting amide local anesthetic that blocks voltage-gated sodium channels and may provide prolonged postoperative analgesia. This quasi-experimental study will compare irrigation of 20 mL of 0.5% bupivacaine versus 20 mL normal saline applied to the gallbladder bed following laparoscopic cholecystectomy. Postoperative pain will be assessed at 4, 8, and 12 hours using VAS scores.

The findings may contribute to improved postoperative pain management protocols and reduced analgesic requirements following laparoscopic cholecystectomy.

Enrollment

64 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 to 60 years
  • Acute cholecystitis confirmed by clinical findings (epigastric pain, abdominal tenderness, positive Murphy sign), ultrasound or CT findings (gallbladder wall thickening, pericholecystic fluid), and raised total leucocyte count and C-reactive protein
  • Planned for laparoscopic cholecystectomy
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Presentation within one week of symptom onset
  • Able to provide written informed consent

Exclusion criteria

  • Known allergy to amide local anaesthetics
  • Uncontrolled hypertension
  • Documented psychiatric disorder
  • Gallbladder empyema, mucocele, or perforation
  • Conversion to open cholecystectomy

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

64 participants in 2 patient groups, including a placebo group

Normal Saline Irrigation Group
Placebo Comparator group
Description:
Patients received 20 mL of 0.9% normal saline irrigated over the gallbladder bed using the same technique and timing as the bupivacaine group. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.
Treatment:
Drug: Normal Saline 0.9%
Bupivacaine Irrigation Group
Experimental group
Description:
Patients received 20 mL of 0.5% bupivacaine irrigated over the gallbladder bed through the lateral-most port immediately after specimen retrieval, before desufflation and port closure. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.
Treatment:
Drug: Bupivacaine 0.5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems